Discontinued — last reported Q4 '25
Business Segments · Impairment of goodwill
Health & Biosciences — Impairment of goodwill
This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ3 2022
Last reportedQ4 2025Feb 27, 2026
Rolls up toGoodwill impairment
How to read this metric
A significant impairment signals that previous acquisitions in this segment have failed to meet performance expectations.
Detailed definition
A non-cash charge recognized when the carrying value of goodwill within the Health & Biosciences segment exceeds its imp...
Peer comparison
Standard 'Goodwill impairment' charge reported under annual impairment testing requirements.
Metric ID:
iff_segment_health_biosciences_impairment_of_goodwillHistorical Data
9 periods
| Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $2.25B | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| QoQ Change | — | -100.0% | — | — | — | — | — | — | — |
| YoY Change | — | — | — | -100.0% | — | — | — | — | — |
Range$0.00 – $2.25B
CAGR-100.0%
Avg YoY Growth-100.0%
Median YoY Growth-100.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is International Flavors & Fragrances's health & biosciences — impairment of goodwill?
- International Flavors & Fragrances (IFF) reported health & biosciences — impairment of goodwill of $0.00 in Q4 2025.
- What does health & biosciences — impairment of goodwill mean?
- A write-down of the value of goodwill in the Health & Biosciences segment due to reduced business expectations.